Clinical Trial Update: Combination Therapy for Warts: Candida Antigen vs. Topical Keratolytic [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing Candida albicans antigen to a topical keratolytic for HPV-related warts has completed. The study evaluated efficacy and safety …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Papillomavirus Infection
• Warts

Drugs mentioned

• Candida albicans antigen (Candida albicans antigen)
• Topical keratolytic agent (topical keratolytic agent)

Snippet

Sponsor: Benha University | Conditions: Warts, Human Papilloma Virus (HPV) | Phase 2 | Status: COMPLETED